Leukemia, acute megakaryoblastic, fab m7, in remis
Megakaryocytic leukemia in relapse
Megakaryocytic leukemia in remission
C94.21 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
The 2023 edition of ICD-10-CM C94.21 became effective on October 1, 2022.
This is the American ICD-10-CM version of C94.21 – other international versions of ICD-10 C94.21 may differ.